Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OLMESARTAN MEDOXOMIL USP, with a corresponding US DMF Number 26035.
Remarkably, this DMF maintains an Active status since its submission on June 01, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 20, 2013, and payment made on December 17, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II